Search

Search Constraints

You searched for: Subject Melanomen

Search Results

4. Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors. Issue 5 (October 2018)

6. Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity. Issue 5 (October 2018)

8. Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma. Issue 5 (October 2018)